Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Effect of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Supplementation on Biomarkers of Sub-Concussion Injuries in American Football

NCT04796207 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT04796207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04796207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Effect of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Supplementation on Biomarkers of Sub-Concussion Injuries in American Football
Lead sponsor
University of Arizona
Phase
Not applicable
Overall status
Completed
Start date
May 28, 2019
Completion date
January 28, 2020
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic traumatic encephalopathy (cte), traumatic brain injury (tbi)